Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $1.44 and last traded at $1.40, with a volume of 9512 shares trading hands. The stock had previously closed at $1.39.
BioRestorative Therapies Stock Performance
The stock’s fifty day moving average price is $1.63 and its two-hundred day moving average price is $1.60. The company has a market cap of $2.30 billion, a P/E ratio of -1.30 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How Investors Can Find the Best Cheap Dividend Stocks
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
